Viewing nowCombinationTradiam Duo Tablet 2.5/500 mg
Linagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.

MFDS item code 201802631 · Approved 2018.06.26 · Insurance code 643705520
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication helps improve blood sugar control in patients with type 2 diabetes by using linagliptin and metformin together. It is more effective when combined with dietary control and exercise therapy, contributing to stable management of blood sugar levels. Therefore, this medication is used for blood sugar control in patients with type 2 diabetes.
The dose of this medication should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended dose of each component: linagliptin 2.5 mg and metformin 1000 mg twice daily. This medication is administered twice daily with meals. To reduce gastrointestinal adverse reactions associated with metformin use, the dose should be increased gradually. 1. Patients not currently receiving metformin: For patients with no prior experience of antidiabetic drug treatment who do not achieve adequate glycemic control with monotherapy, the initial dose is 1 tablet of this medication 2.5/500 mg twice daily; the dose may be increased to 1 tablet of this medication 2.5/1000 mg twice daily. 2. Switching from linagliptin and metformin combination therapy: Patients switching from linagliptin and metformin combination therapy to this medication should take the same doses of linagliptin and metformin that they were previously taking as the initial dose. 3. Inadequate glycemic control with insulin and metformin combination therapy: The initial dose should be considered to be linagliptin 2.5 mg twice daily (total daily dose 5 mg) and a dose similar to the patient's current metformin dose. When this medication is administered with insulin, a reduction in the insulin dose may be necessary to reduce the risk of hypoglycemia. Patients with renal impairment This medication may be used in patients with moderate renal impairment stage 3a (creatinine clearance [CrCl] 45≤~<60 ml/min or estimated glomerular filtration rate (eGFR) 45≤~<60 mL/min/1.73 m2) who have no other conditions that may increase the risk of lactic acidosis, with the following dose adjustment. Because the starting dose of metformin is 500mg or 850mg once daily, treatment should not be initiated with this medication. The maximum recommended dose of metformin is 500 mg twice daily. Renal function should be monitored carefully every 3-6 months. If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medication should be discontinued immediately. Patients with hepatic impairment This medication should not be administered to patients with hepatic impairment because it contains metformin.
This medication is primarily used to control blood sugar levels. During the use of this medication, a rare complication called lactic acidosis may occur, so it is essential to check kidney and liver function before taking it. Patients with severely impaired kidney function or liver function problems, as well as those with acute illness or dehydration, should not take this medication. Additionally, it is not administered to patients with type 1 diabetes or those suffering from diabetic ketoacidosis or diabetic pre-coma. It is also recommended that pregnant or breastfeeding women refrain from using this medication. This medication may cause hypoglycemia, so blood sugar must be monitored closely, especially when taken with insulin or sulfonylureas. It is important to regularly check kidney function during the use of this medication to ensure no abnormalities occur. Acute pancreatitis or skin blistering disorders may appear, so if there are continuous abdominal pain or skin abnormalities, consult a doctor immediately. The risk of lactic acidosis increases when this medication is taken with alcohol, so alcohol consumption should be avoided. Additionally, during the use of this medication, it may be necessary to temporarily interrupt drug use before and after certain radiological tests. In elderly patients, the decline in kidney function is common, so kidney function should be monitored more closely during the use of this medication. The safety and efficacy of this medication have not been established in children, so it is not recommended for children under 10 years of age. If any unusual symptoms or discomfort occur during the use of the medication, it is important to consult a medical professional immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, preferably at room temperature between 1°C and 30°C. This storage helps maintain the medication's effectiveness and prevents degradation.
Bright yellow, biconvex, oval film-coated tablet
30 tablets/box[(6 tablets/PTP x 5 packs)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Anguk Pharm Co., Ltd.
Linagliptin 2.5mg · Metformin Hydrochloride 1000mg
Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationLinagliptin 2.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kookje Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.